| HOME >> BIOLOGY >> TECHNOLOGY |
Cash and investments * $118,641 $152,016
Total assets 186,143 215,609
Total liabilities 300,375 270,988
Total shareholders' equity (114,232) (55,379)
* Cash and investments include cash equivalents and restricted cash equivalents
Any statements contained in this presentation that relate to future plans, events or performance are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results, and the timing of events, to differ materially from those described in the forward-looking statements. These risks and uncertainties include, among others, those relating to technology and product development, integration of acquired businesses, market acceptance, government regulation and regulatory approval processes, intellectual property rights and litigation, dependence on collaborative relationships, ability to obtain financing, competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission deCODE undertakes no obligation to update or alter these forward-looking statements as a result of new information, future events or otherwise.
| SOURCE deCODE genetics Copyright©2007 PR Newswire. All rights reserved |